# Simulations Plus Inc. (SLP) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Providers & Services. Price $18.43, market value $373 million.

## Valuation
- **P/E (trailing): 46.1×** (5-yr avg 88.9×, 3-yr avg 82.1×). Simulations Plus Inc. trades at 46.1× trailing earnings, well below its own five-year average of 88.9×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 20.9×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 4.5×**. Each dollar of revenue is priced at 4.5×.
- **Price / book: 2.7×**. The shares trade at 2.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 20.2×**. Enterprise value is 20.2× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 6.6%** (5-yr avg 2.7%). Free cash flow equals 6.6% of the market value, above its five-year average of 2.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 2.2%**. The inverse of the P/E: 2.2% of the price is earned each year.

## Profitability
- **Gross margin: 63.4%**. Simulations Plus Inc. keeps 63.4% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 14.0%**. 14.0% of revenue is left after running the business.
- **Net margin: -81.7%**. The company reported a net loss over the last twelve months.
- **Return on equity: -51.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 9.3%**. Return on all capital, debt included, is 9.3%.
- **Return on assets: 6.1%**. Each dollar of assets produces 6.1% of profit.

## Growth
- **Revenue growth (1 yr): 13.1%** (3-yr 13.7%/yr, 5-yr 13.7%/yr). Revenue grew 13.1% over the last year, against 13.7% a year compounded over five years.
- **EPS growth (1 yr): -757.1%**. Earnings per share fell 757.1%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 0.6%/yr**. Free cash flow has compounded at 0.6% a year over three years.

## Financial health
- **Debt to equity: 0.03**. Debt is 0.03 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Simulations Plus Inc. holds more cash than debt.
- **Current ratio: 7.67** (quick 7.67). Current assets cover the next year's liabilities 7.67 times.
- **Altman Z-score: 31.91**. A Z-score of 31.91 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Simulations Plus Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 30.5%** (YTD 1.1%, 3-mo 16.1%). The shares are up 30.5% over twelve months including dividends.
- **From 52-week high: -12.3%** (66.2% above the low). Trading 12% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 64**. An RSI of 64 is neutral.
- **Beta (1 yr): 1.03** (volatility 48%). Beta of 1.03 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SLP · Page: https://foliofundamentals.com/stocks/slp

Not investment advice.